-
ADR
- MOA
- PREVALENCE
- RELATIVE EFFECTS
- TREATMENT
- SYMPTOMS
- NB
-
DYSTONIA
- Oculogyric crisis, torticollis
- 10% with typicals
- Anticholenergics (AC)
- more likely in early stages, inc dose, may occur on withdrawal
- Less with atypicals
-
PSEUDOPARKINSONISM
- Bradykinesia, tremors, rigidity
- 20% with typicals
- AC (NOT D agonists)
- ACs have ADR, can be abused for street value
- as above
-
AKATHESIA
- subjective unpleasent state of motor restlessness -->anxiety, dysphoria
- 20-25% with typicals
- Propranolol, Cyproheptidine (anti-hista)
- Try atypicals
- Poor response with AC
- LINKED TO VIOLENCE AND SUICIDE
- as above
- Good: QUET, OLANZ
-
TARDIVE DYSKINESIA
- Supersensitivity to D receptors
- GABA pathways
- ~20% , typicals
- STOP/ REDUCE AC, dec AP dose, try atypicals
- CLOZAPINE- MAY TREAT IT!
- TETRABENAZINE IS THE ONLY LICENCED RX IN UK
- HIGH RISK GROUP: affective illness, DM, LD, women, elderly
- as above
-
HYPERPROLACTINEMIA
- Prolactin is under inhibitory control of Dopamine
- GOOD : CLOZ, OLANZ, QUET, ARIP, ZIPRA
- galactorrhoea, amenorrhoea, gynecomastia, hypogonadism, sexual dysfn, inc risk of osteoporosis
- x9 inc risk of BREAST CANCER
- SWITCH to non-pro drugs
- ~dopamine agonists (may worsen psychosis)
- BAD : RISP, AMISULP, ZOTEPINE
-
REDUCED SEIZURE THRESHOLD
- GOOD: SULP, TFP, HALO
- BAD :CLOZAPINE
- The more sedative and less potent drugs carry a higher risk than the more potent, less sedative drug
- 4-5% with CLOZ
-
POSTURAL HYPO
- Adrenergic alpha-1 blockade
- BAD : CLOZ, RISP, QUET, SERTINDOLE (so titrate doses)
-
ANTICHOLENERGIC EFFECTS
- dry mouth, constipation, uri retention, blurred vision, cog impair
- BAD :CLOZAPINE
- GOOD: HALO, SULP, TFP
-
NMS
- Rapid blockade of hypothalamic and straital dopamine receptors --> resetting of thermoreg systems
- 0.5% in FGAs
- Mortality - 20%
- All antipsychotics, Lithium, SSRIs, MAOI, TCA
- WORST - HALO
- mild HYPERthermia, fluctiating conc, muscular rigidity, autonomic instability, severe EPSEs,
- Raised serum CPK, Leucocytosis (WITH LEFT SHIFT), abnormal LFTs
- MAU- wITHdraw AP, monitor, rehydrate, sedate with benzo
- BROMOCRIPTINE + DANDROLENE
-
WEIGHT GAIN
- Insulin resistance, hyperprotactenemia, inc serum leptin
- 5-HT 2c and H1 blockade
- BAD: CLOZ, OLANZ, ZOTE
- GOOD: ARIP, AMISULP, HALO, TFP, ZIPRA
- OK: QUET, RISP, CPZ
- Switch
- Amantadine, bupropion, orlistat, etc
-
QT prolongation
- High effect - HALO
- No effect- ARIP
- LOW EFFECT - AMISULP, CLOZ, OLANZ, RISP, SULP
- Mod effect- QUET, ZOTEP
- QTc <440,M AND <470, F --> NO Action reqd
- QTc >440,m ,>470, f but <500 --> ECG, switch, cardiologist
- QTC >500 --> sTOP, Switch, Cardio ref immidiately
-
DM, IGT
- Insulin resistance, hyperglycemia, IGT, DKA
- ~1/3rd may develop DM after 2 yrs of Rx
- GOOD: AMISULP, ARIP, ZIPRA
- BAD :CLOZ> OLANZ > RISP > QUET
- Schizo itself is asso with DM
- OGTT IS THE MOST SENSITIVE Ix
- P Is 2-3 times the general pop
-
Dyslipedemia
- OLANZ IS THE WORST
- Inc TG AND LDL and dec HDL
- THEN CLOZ, RISP AND QUET
- ARIP AND HALO - ALMOST NONE
- Monitor- Fasting lipids at baseline, then every 3 mth for a yr,then annually
-
Sexual dysfunction
- Dec dopaminergic trans, hyperprolactin, sedation , wt gain, anti-cholinergic effect
- 45% on typicals
- OLAZ- LESS
-
Subtopic 4
- RISP- Retrograde ejac, Inc prolactin, priapism
- QUET, CLOZ- ~low
- ARIP- ~none
- Topic
- Bromocriptine, amantadine - for hyperprolactin
- Alprostadil, sildenafil - for erectile dysfn
- Bethanecol for AC effects
-
Hyponatremia
- Water intoxication (sec to fluid overload)
- SIADH
- Pseudohyponatremia sue to hyperlipedemia, hyperglycemia
- 5%
- 11%
- All are implicated but least with CLozapine
- Fluid restriction, try Clozapine
- Demeclocycline for SIADH